glp-1 weight loss drugs Popular medications may have health benefits that extend beyond and blood sugar control, a new study finds GLP-1 weight loss drugs may

Nausea was the most common adverse event, significantly higher in the GLP-1RA group compared to placebo

We cannot guarantee approval, but clean documentation matters

In one of two recently published studies in JAMA Neurology , Allie Seminer , MSc , and Alfredi Mulihano , undergraduate students in the School of Medicine at the University of Galway in Ireland, and colleagues found that GLP-1 receptor agonists significantly reduced the risk for all-cause dementia, but SGLT2 inhibitors did not

Cited 2/7/17

In comparison to other antihyperglycaemic agents, DPP-4 inhibitors lowered total cholesterol slightly more than other agents (total cholesterol 0.18 [0.29

doi: 10.1136/bmjopen-2022-061807 [DOI] [PMC free article] [PubMed] [Google Scholar] 88.Dahl D, Onishi Y, Norwood P, et al